| Quarter | Holdings | Value, Excl. Options ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2026 | 194 | 787,821 | LEXI, AAPL, NVDA, IVW | 13F-HR | 10/28/2026 | 000181839126000005 |
| Q2 2026 | 194 | 766,307 | LEXI, AAPL, NVDA, IVW | 13F-HR | 7/29/2026 | 000181839126000003 |
| Q1 2026 | 185 | 679,127 | LEXI, AAPL, NVDA, IVW | 13F-HR | 4/27/2026 | 000181839126000002 |
| Q4 2025 | 173 | 544,312 | AAPL, NVDA, LEXI, IVW | 13F-HR | 2/5/2026 | 000181839126000001 |
| Q3 2025 | 178 | 562,969 | IVW, AAPL, COST, NVDA | 13F-HR | 10/23/2025 | 000181839125000002 |
| Q2 2025 | 178 | 512,189 | COST, IVW, AAPL, NVDA | 13F-HR | 7/23/2025 | 000108514625004052 |
| Q1 2025 | 173 | 446,724 | COST, IVW, IVE, AAPL | 13F-HR | 4/23/2025 | 000108514625002266 |
| Q4 2024 | 171 | 457,315 | COST, IVW, AAPL, IVE | 13F-HR | 2/11/2025 | 000108514625000983 |
| Q3 2024 | 164 | 442,371 | IVE, COST, IVW, AAPL | 13F-HR | 12/19/2024 | 000108514624006074 |
| Q2 2024 | 168 | 436,451 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006073 |
| Q1 2024 | 171 | 421,268 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006072 |
| Q4 2023 | 166 | 389,851 | IVE, IVW, COST, AGG | 13F-HR | 12/19/2024 | 000108514624006071 |
| Q3 2023 | 200 | 363,255 | NXPI calls, IVE, IVW, COST | 13F-HR | 12/19/2024 | 000108514624006070 |
| Q2 2023 | 219 | 370,507 | NXPI calls, IVE, COST, IVW | 13F-HR | 12/19/2024 | 000108514624006069 |
| Q1 2023 | 210 | 339,245 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006068 |
| Q4 2022 | 213 | 328,263 | IVE, AGG, COST, IVW | 13F-HR | 12/19/2024 | 000108514624006067 |
| Q3 2022 | 208 | 304,983 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006066 |
| Q2 2022 | 216 | 320,859 | IVE, COST, AGG, IVW | 13F-HR | 12/19/2024 | 000108514624006065 |
| Q1 2022 | 213 | 391,587 | NXPI calls, IVE, IVW, COST | 13F-HR | 12/19/2024 | 000108514624006064 |
| Q4 2021 | 226 | 423,731 | IVE, IVW, AGG, COST | 13F-HR | 12/19/2024 | 000108514624006062 |
| Q3 2021 | 212 | 403,324 | IVE, IVW, AGG, COST | 13F-HR | 12/19/2024 | 000108514624006061 |
| Q2 2021 | 202 | 411,656 | IVE, IVW, AGG, GVI | 13F-HR | 12/19/2024 | 000108514624006060 |
| Q1 2021 | 188 | 364,075 | IVE, IVW, AGG, GVI | 13F-HR | 12/19/2024 | 000108514624006059 |
| Q4 2020 | 178 | 320,280 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006058 |
| Q3 2020 | 159 | 262,122 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006057 |
| Q2 2020 | 151 | 233,840 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006056 |
| Q1 2020 | 127 | 180,971 | IVE, IVW, AGG, ITOT | 13F-HR | 12/19/2024 | 000108514624006055 |
| Q4 2019 | 155 | 225,888 | IVE, IVW, ITOT, AGG | 13F-HR | 12/13/2024 | 000108514624006049 |
1 security where the latest filing since 12/18/2024 is a 13G, filed 2/14/2025. View all